| 0 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
21 |
0.0376 |
| 1 |
BREAKTHROUGH HAEMOLYSIS |
10 |
0.0251 |
| 2 |
EXTRAVASCULAR HAEMOLYSIS |
6 |
0.0141 |
| 3 |
MENINGOCOCCAL BACTERAEMIA |
1 |
0.0104 |
| 4 |
PANCREATIC ENZYME ABNORMALITY |
1 |
0.0098 |
| 5 |
BILIRUBINURIA |
1 |
0.0095 |
| 6 |
COMPLEMENT FACTOR ABNORMAL |
1 |
0.0093 |
| 7 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
1 |
0.0050 |
| 8 |
PURPURA FULMINANS |
1 |
0.0039 |
| 9 |
MENINGOCOCCAL INFECTION |
1 |
0.0032 |
| 10 |
ACTIVITIES OF DAILY LIVING DECREASED |
2 |
0.0031 |
| 11 |
HAEMOLYSIS |
14 |
0.0018 |
| 12 |
INTRAVASCULAR HAEMOLYSIS |
1 |
0.0018 |
| 13 |
ENTERITIS INFECTIOUS |
3 |
0.0018 |
| 14 |
BILIARY TRACT INFECTION |
1 |
0.0016 |
| 15 |
SERUM SICKNESS-LIKE REACTION |
1 |
0.0016 |
| 16 |
GASTROINTESTINAL MUCOSAL DISORDER |
1 |
0.0015 |
| 17 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 18 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 19 |
VASCULITIC RASH |
1 |
0.0013 |
| 20 |
KETONURIA |
1 |
0.0012 |
| 21 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 22 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 23 |
PULPITIS DENTAL |
1 |
0.0011 |
| 24 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 25 |
HAEMOGLOBINURIA |
1 |
0.0009 |
| 26 |
EMBOLISM ARTERIAL |
1 |
0.0008 |
| 27 |
VASCULAR PURPURA |
1 |
0.0007 |
| 28 |
PRERENAL FAILURE |
1 |
0.0007 |
| 29 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 30 |
IMMUNE-MEDIATED ADVERSE REACTION |
1 |
0.0007 |
| 31 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 32 |
SUDDEN HEARING LOSS |
1 |
0.0005 |
| 33 |
HYPERURICAEMIA |
2 |
0.0005 |
| 34 |
SPUTUM INCREASED |
1 |
0.0005 |
| 35 |
HENOCH-SCHONLEIN PURPURA |
1 |
0.0005 |
| 36 |
INFECTION SUSCEPTIBILITY INCREASED |
1 |
0.0005 |
| 37 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 38 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 39 |
APLASTIC ANAEMIA |
2 |
0.0004 |
| 40 |
BREAST SWELLING |
1 |
0.0004 |
| 41 |
SERUM SICKNESS |
1 |
0.0004 |
| 42 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 43 |
CHOLECYSTITIS |
4 |
0.0003 |
| 44 |
BRAIN HERNIATION |
1 |
0.0003 |
| 45 |
POLYMYALGIA RHEUMATICA |
1 |
0.0003 |
| 46 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 47 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 48 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 49 |
AMYLASE INCREASED |
1 |
0.0003 |
| 50 |
POLYDIPSIA |
1 |
0.0003 |
| 51 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 52 |
ANURIA |
2 |
0.0002 |
| 53 |
OCULAR ICTERUS |
1 |
0.0002 |
| 54 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 55 |
HEPATIC FUNCTION ABNORMAL |
8 |
0.0002 |
| 56 |
YELLOW SKIN |
1 |
0.0002 |
| 57 |
PULSE ABSENT |
1 |
0.0002 |
| 58 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 59 |
NECROSIS |
1 |
0.0002 |
| 60 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 61 |
ENTEROCOLITIS |
1 |
0.0002 |
| 62 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 63 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 64 |
CHOLANGITIS |
1 |
0.0002 |
| 65 |
PROCTALGIA |
1 |
0.0002 |
| 66 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 67 |
JAUNDICE |
4 |
0.0001 |
| 68 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 69 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 70 |
FURUNCLE |
1 |
0.0001 |
| 71 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 72 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 73 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 74 |
ANAEMIA |
20 |
0.0001 |
| 75 |
TRANSFUSION |
1 |
0.0001 |
| 76 |
BREAST PAIN |
1 |
0.0001 |
| 77 |
SEPTIC SHOCK |
4 |
0.0001 |
| 78 |
VASCULITIS |
1 |
0.0001 |
| 79 |
BACTERAEMIA |
1 |
0.0001 |
| 80 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 81 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 82 |
CYTOPENIA |
1 |
0.0001 |
| 83 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 84 |
INFECTION |
11 |
0.0001 |
| 85 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 86 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 87 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 88 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 89 |
GASTROENTERITIS |
1 |
0.0001 |
| 90 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 91 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 92 |
SEPSIS |
7 |
0.0001 |
| 93 |
PYREXIA |
21 |
0.0001 |
| 94 |
CELLULITIS |
3 |
0.0001 |
| 95 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 96 |
FLUID RETENTION |
3 |
0.0001 |
| 97 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 98 |
DRUG ERUPTION |
1 |
0.0001 |
| 99 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 100 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 101 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 102 |
CARDIAC FAILURE |
4 |
0.0000 |
| 103 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 104 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 105 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 106 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 107 |
SHOCK |
1 |
0.0000 |
| 108 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 109 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 110 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 111 |
COVID-19 |
7 |
0.0000 |
| 112 |
INFLAMMATION |
2 |
0.0000 |
| 113 |
SKIN ULCER |
1 |
0.0000 |
| 114 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 115 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 116 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 117 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 118 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 119 |
PNEUMONIA |
10 |
0.0000 |
| 120 |
CHOLELITHIASIS |
1 |
0.0000 |
| 121 |
URINARY RETENTION |
1 |
0.0000 |
| 122 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 123 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 124 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 125 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 126 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 127 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 128 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 129 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 130 |
LIVER DISORDER |
1 |
0.0000 |
| 131 |
DEHYDRATION |
3 |
0.0000 |
| 132 |
DRY SKIN |
3 |
0.0000 |
| 133 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 134 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 135 |
RENAL DISORDER |
1 |
0.0000 |
| 136 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 137 |
LEUKOPENIA |
1 |
0.0000 |
| 138 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 139 |
MEDICATION ERROR |
1 |
0.0000 |
| 140 |
FLATULENCE |
1 |
0.0000 |
| 141 |
SEIZURE |
2 |
0.0000 |
| 142 |
OFF LABEL USE |
15 |
0.0000 |
| 143 |
BONE PAIN |
1 |
0.0000 |
| 144 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 145 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 146 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 147 |
ARTHRALGIA |
6 |
0.0000 |
| 148 |
CONSTIPATION |
3 |
0.0000 |
| 149 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 150 |
DRUG INTERACTION |
2 |
0.0000 |
| 151 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 152 |
URTICARIA |
2 |
0.0000 |
| 153 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 154 |
PRURITUS |
4 |
0.0000 |
| 155 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 156 |
HEADACHE |
6 |
0.0000 |
| 157 |
HYPERTENSION |
2 |
0.0000 |
| 158 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 159 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 160 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 161 |
PALPITATIONS |
1 |
0.0000 |
| 162 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 163 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 164 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 165 |
NAUSEA |
6 |
0.0000 |
| 166 |
INSOMNIA |
2 |
0.0000 |
| 167 |
NEUTROPENIA |
1 |
0.0000 |
| 168 |
RASH |
3 |
0.0000 |
| 169 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 170 |
VOMITING |
3 |
0.0000 |
| 171 |
FALL |
2 |
0.0000 |
| 172 |
MYALGIA |
1 |
0.0000 |
| 173 |
CHEST PAIN |
1 |
0.0000 |
| 174 |
PAIN |
3 |
0.0000 |
| 175 |
MALAISE |
2 |
0.0000 |
| 176 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 177 |
DECREASED APPETITE |
1 |
0.0000 |
| 178 |
FEELING ABNORMAL |
1 |
0.0000 |
| 179 |
FATIGUE |
3 |
0.0000 |
| 180 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 181 |
DIARRHOEA |
2 |
0.0000 |
| 182 |
ASTHENIA |
1 |
0.0000 |
| 183 |
DIZZINESS |
1 |
0.0000 |
| 184 |
DYSPNOEA |
1 |
0.0000 |